Seeger Weiss Receives Highest Honors in 2024 Chambers Guide

Seeger Weiss is proud to announce that the firm, alongside partners Chris Seeger and Dave Buchanan, has been recognized in Band 1 for Product Liability: Plaintiffs in the newly released Chambers 2024 USA Guide. Additionally, partner Benjamin Barnett has been recognized for his contributions to E-Discovery & Information Governance. For more than 30 years, Chambers […]

June 7, 2024

Seeger Weiss is proud to announce that the firm, alongside partners Chris Seeger and Dave Buchanan, has been recognized in Band 1 for Product Liability: Plaintiffs in the newly released Chambers 2024 USA Guide. Additionally, partner Benjamin Barnett has been recognized for his contributions to E-Discovery & Information Governance. For more than 30 years, Chambers has been an authoritative source of legal rankings and insights, with selection to their guides regarded as one of the most prestigious awards for practicing attorneys.

This guide marks the fourth consecutive year that Seeger Weiss has been ranked, and this year, the firm is rated in Band 1 of the Chambers USA Product Liability: Plaintiffs guide. Band 1 is the highest ranking that a nominee can achieve and is based on technical legal ability, professional conduct, client service, commercial astuteness, diligence, commitment, and other qualities most valued by the client. Seeger Weiss’ Chambers profile notes that the firm is “highly regarded for its representation of plaintiffs in mass tort litigation related to opioids, emissions, and data security matters.” The firm is “well known for expertise in settling complex multidistrict litigation mandates in both federal and state courts.”

For his 18th consecutive year, founding partner Chris Seeger was named to the Chamber’s annual guide. This year, Chris was listed in Band 1 for Product Liability: Plaintiffs. On Chris’ Chambers page, it highlights that he is a “highly acclaimed practitioner who frequently acts on concussion class actions and automotive cases” and is “particularly esteemed for his work on opioid litigation.”

Partner Dave Buchanan was also ranked in Band 1 for Product Liability: Plaintiffs, marking the 10th consecutive year Dave has been featured in Chambers’ annual guide. Dave’s Chambers page remarks that he is a “renowned trial lawyer who has acted on high-profile cases including opioid litigation, pharmaceutical cases and consumer products.”

One of our newest partners, Ben Barnett, was ranked in Band 3 for E-Discovery & Information Governance. Ben has made the Chambers’ annual guide for 12 consecutive years. According to his Chambers profile, Ben is “regularly called on to advise on data governance strategies.” He is also said to be a key attorney for “advising on discovery issues arising in major litigation matters.”

Chambers identifies the best practice groups and lawyers in 200 jurisdictions across the globe. The guide’s selection process is performed through in-depth market analysis and independent research conducted by a dedicated team of Research Analysts who speak to law firm clients/referees to analyze the level of client services and work each submitting law firm offers. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

October 25, 2026
Seeger Weiss Partner Christopher A. Seeger Receives Inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law

Seeger Weiss Partner Christopher Seeger received the inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law, his alma mater, at the school’s 50th Anniversary Gala at the Hall des Lumières in New York City on October 22, 2026. The award is named for Monroe Price, who served as Dean of Cardozo […]

Read More
October 23, 2026
Seeger Weiss’s Christopher A. Seeger Appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation

Seeger Weiss LLP is pleased to announce that Partner Christopher A. Seeger has been appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation, MDL No. 3180, pending in the U.S. District Court for the District of New Jersey. The litigation involves claims that Dupixent, an injectable biologic prescribed to treat inflammatory conditions including […]

Read More
September 15, 2026
Lawdragon Names Seven Seeger Weiss Partners to 2027 500 Leading Litigators in America Guide

Lawdragon has recognized seven Seeger Weiss partners—Christopher Seeger, Stephen Weiss, Parvin Aminolroaya, Ben Barnett, David Buchanan, Shauna Itri, and Jennifer Scullion—in its 2027 Lawdragon 500 Leading Litigators in America guide. The guide highlights attorneys whose courtroom, investigative, and regulatory work has produced real impacts for the clients they represent, with many honorees credited with influencing entire […]

Read More
↑